Clinical trials
Burkitt Lymphoma trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
62 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 3 |
| 2004 | 3 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2019 | 6 |
| 2020 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 35 |
| Recruiting | 12 |
| Active, not recruiting | 6 |
| Terminated | 5 |
| Unknown status | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Oncology Group | 14 |
| National Cancer Institute (NCI) | 14 |
| NCIC Clinical Trials Group | 5 |
| Novartis Pharmaceuticals | 4 |
| Alliance for Clinical Trials in Oncology | 2 |
| AstraZeneca | 2 |
| Merck Sharp & Dohme LLC | 2 |
| American College of Radiology Imaging Network | 1 |
| Amgen Research (Munich) GmbH | 1 |
| Ascentage Pharma Group Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Burkitt Lymphoma | 62 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 33 |
| Lymphoma | 26 |
| Lymphoma, Large B-Cell, Diffuse | 26 |
| Lymphoma, Non-Hodgkin | 17 |
| Lymphoma, Follicular | 16 |
| Dendritic Cell Sarcoma, Interdigitating | 15 |
| Leukemia | 15 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 15 |
| Lymphoma, Large-Cell, Immunoblastic | 14 |
Trials
Showing 76 to 62 of 62. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.